Catasys, Inc. (NASDAQ:CATS) has received a consensus broker rating score of 2.00 (Buy) from the one brokers that cover the stock, Zacks Investment Research reports. One analyst has rated the stock with a buy rating. Catasys’ rating score has declined by 100% in the last 90 days as a result of a number of analysts’ upgrades and downgrades.

Brokers have set a 1 year consensus target price of $5.30 for the company and are predicting that the company will post ($0.09) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Catasys an industry rank of 205 out of 265 based on the ratings given to related companies.

A number of research analysts have issued reports on CATS shares. Telsey Advisory Group started coverage on shares of Catasys in a research report on Wednesday, October 18th. They set a “buy” rating on the stock. Zacks Investment Research cut shares of Catasys from a “hold” rating to a “sell” rating in a report on Tuesday, December 19th. ValuEngine cut shares of Catasys from a “hold” rating to a “sell” rating in a report on Saturday, October 21st. Finally, Taglich Brothers started coverage on shares of Catasys in a report on Wednesday, October 18th. They set a “speculative buy” rating and a $8.00 target price on the stock.

Several hedge funds have recently made changes to their positions in the company. FNY Partners Fund LP bought a new stake in shares of Catasys during the 2nd quarter valued at $1,560,000. Kennedy Capital Management Inc. bought a new stake in shares of Catasys during the 2nd quarter valued at $1,385,000. Bard Associates Inc. bought a new stake in shares of Catasys during the 2nd quarter valued at $1,012,000. Finally, UBS Oconnor LLC bought a new stake in shares of Catasys during the 2nd quarter valued at $834,000. Hedge funds and other institutional investors own 6.39% of the company’s stock.

Shares of Catasys (NASDAQ CATS) traded down $0.07 during trading on Friday, reaching $3.88. 43,000 shares of the company’s stock were exchanged, compared to its average volume of 63,833. The stock has a market cap of $62.76, a P/E ratio of -2.22 and a beta of -0.29. Catasys has a fifty-two week low of $3.30 and a fifty-two week high of $14.00.

ILLEGAL ACTIVITY WARNING: “Analysts Set $5.30 Target Price for Catasys, Inc. (CATS)” was originally reported by American Banking News and is the property of of American Banking News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/05/analysts-set-5-30-target-price-for-catasys-inc-cats.html.

About Catasys

Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company’s OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.

Get a free copy of the Zacks research report on Catasys (CATS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.